Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jeff Bronstein MD, PhD

Jeff M. Bronstein MD, PhD

Professor of Neurology; Fred Silton Family Chair in Movement Disorders; Director of Movement Disorders, David Geffen School of Medicine at UCLA, Los Angeles, California

Jeff Bronstein received his bachelor’s degree from the University of California, Berkeley and MD and PhD from UCLA as a recipient of the Medical Scientist Training Program Award. He completed a residency in Neurology and fellowship training in Movement Disorders at UCLA and at Queens Square in London.

Dr. Bronstein also completed a postdoctoral fellowship in molecular biology before being appointed Director of the Movement Disorders Program at UCLA in 1996, Professor of Neurology in 2006, and Professor of Molecular Toxicology in 2007. He directs a Wilson’s Disease Association Center of Excellence and a basic science laboratory investigating the causes of Parkinson’s disease (environmental and genetic) using cell and zebrafish models as well as population-based studies.

His clinical interests include the medical and surgical management of Parkinson’s disease, Wilson’s disease and other movement disorders. Dr. Bronstein active research program includes clinical trials to develop new therapies.


Dr. Bronstein reports the following:
  • Alexion: Consultant and site PI for clinical trial
  • Ultragenix: Consultant and site PI for clinical trial